Melanoma, Experimental

"Melanoma, Experimental" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Experimentally induced tumor that produces MELANIN in animals to provide a model for studying human MELANOMA.

Descriptor ID	D008546
MeSH Number(s)	C04.557.465.625.650.510.525 C04.557.580.625.650.510.525 C04.557.665.510.525 C04.619.600 E05.598.500.496.937
Concept/Terms	Melanoma, Experimental Melanoma, Experimental Melanomas, Experimental Experimental Melanoma Experimental Melanomas Melanoma, Harding-Passey Melanoma, Harding-Passey Harding-Passey Melanoma Melanoma, Harding Passey Harding Passey Melanoma Melanoma, B16 Melanoma, B16 B16 Melanomas Melanomas, B16 B16 Melanoma Melanoma, Cloudman S91 Melanoma, Cloudman S91 Cloudman S91 Melanoma S91 Melanoma, Cloudman

Below are MeSH descriptors whose meaning is more general than "Melanoma, Experimental".

Diseases [C]
Neoplasms [C04]
Neoplasms by Histologic Type [C04.557]
Neoplasms, Germ Cell and Embryonal [C04.557.465]
Neuroectodermal Tumors [C04.557.465.625]
Neuroendocrine Tumors [C04.557.465.625.650]
Melanoma [C04.557.465.625.650.510]
Melanoma, Experimental [C04.557.465.625.650.510.525]
Neoplasms, Nerve Tissue [C04.557.580]
Neuroectodermal Tumors [C04.557.580.625]
Neuroendocrine Tumors [C04.557.580.625.650]
Melanoma [C04.557.580.625.650.510]
Melanoma, Experimental [C04.557.580.625.650.510.525]
Nevi and Melanomas [C04.557.665]
Melanoma [C04.557.665.510]
Melanoma, Experimental [C04.557.665.510.525]
Neoplasms, Experimental [C04.619]
Melanoma, Experimental [C04.619.600]
Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Investigative Techniques [E05]
Models, Animal [E05.598]
Disease Models, Animal [E05.598.500]
Neoplasms, Experimental [E05.598.500.496]
Melanoma, Experimental [E05.598.500.496.937]

Below are MeSH descriptors whose meaning is related to "Melanoma, Experimental".

Below are MeSH descriptors whose meaning is more specific than "Melanoma, Experimental".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Melanoma, Experimental" by people in this website by year, and whether "Melanoma, Experimental" was a major or minor topic of these publications.

Bar chart showing 13 publications over 11 distinct years, with a maximum of 2 publications in 2018 and 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1993	1	0	1
1996	0	1	1
2000	1	0	1
2003	1	0	1
2005	1	0	1
2012	0	1	1
2013	0	1	1
2017	1	0	1
2018	1	1	2
2020	2	0	2
2021	1	0	1

Below are the most recent publications written about "Melanoma, Experimental" by people in Profiles.

Singh MP, Sethuraman SN, Miller C, Malayer J, Ranjan A. Boiling histotripsy and in-situ CD40 stimulation improve the checkpoint blockade therapy of poorly immunogenic tumors. Theranostics. 2021; 11(2):540-554.

View in: PubMed
Moku G, Vangala S, Gulla SK, Yakati V. In vivo Targeting of DNA Vaccines to Dendritic Cells via the Mannose Receptor Induces Long-Lasting Immunity against Melanoma. Chembiochem. 2021 02 02; 22(3):523-531.

View in: PubMed
Simões IT, Aranda F, Casadó-Llombart S, Velasco-de Andrés M, Català C, Álvarez P, Consuegra-Fernández M, Orta-Mascaró M, Merino R, Merino J, Alberola-Ila J, González-Aseguinolaza G, Carreras E, Martínez V, Lozano F. Multifaceted effects of soluble human CD6 in experimental cancer models. J Immunother Cancer. 2020 03; 8(1).

View in: PubMed
Sethuraman SN, Singh MP, Patil G, Li S, Fiering S, Hoopes PJ, Guha C, Malayer J, Ranjan A. Novel calreticulin-nanoparticle in combination with focused ultrasound induces immunogenic cell death in melanoma to enhance antitumor immunity. Theranostics. 2020; 10(8):3397-3412.

View in: PubMed
Gulla SK, Rao BR, Moku G, Jinka S, Nimmu NV, Khalid S, Patra CR, Chaudhuri A. In vivo targeting of DNA vaccines to dendritic cells using functionalized gold nanoparticles. Biomater Sci. 2019 Feb 26; 7(3):773-788.

View in: PubMed
Zhou B, Song J, Wang M, Wang X, Wang J, Howard EW, Zhou F, Qu J, Chen WR. BSA-bioinspired gold nanorods loaded with immunoadjuvant for the treatment of melanoma by combined photothermal therapy and immunotherapy. Nanoscale. 2018 Nov 29; 10(46):21640-21647.

View in: PubMed
Fujiwara Y, Sun Y, Torphy RJ, He J, Yanaga K, Edil BH, Schulick RD, Zhu Y. Pomalidomide Inhibits PD-L1 Induction to Promote Antitumor Immunity. Cancer Res. 2018 12 01; 78(23):6655-6665.

View in: PubMed
Elechalawar CK, Sridharan K, Pal A, Ahmed MT, Yousuf M, Adhikari SS, Banerjee R. Cationic folate-mediated liposomal delivery of bis-arylidene oxindole induces efficient melanoma tumor regression. Biomater Sci. 2017 Aug 22; 5(9):1898-1909.

View in: PubMed
Gangjee A, Namjoshi OA, Yu J, Ihnat MA, Thorpe JE, Bailey-Downs LC. N2-Trimethylacetyl substituted and unsubstituted-N4-phenylsubstituted-6-(2-pyridin-2-ylethyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamines: design, cellular receptor tyrosine kinase inhibitory activities and in vivo evaluation as antiangiogenic, antimetastatic and antitumor agents. Bioorg Med Chem. 2013 Mar 01; 21(5):1312-23.

View in: PubMed
Gangjee A, Zhao Y, Ihnat MA, Thorpe JE, Bailey-Downs LC, Kisliuk RL. Novel tricyclic indeno[2,1-d]pyrimidines with dual antiangiogenic and cytotoxic activities as potent antitumor agents. Bioorg Med Chem. 2012 Jul 15; 20(14):4217-25.

View in: PubMed

People

Explore

Similar Concepts

Top Journals